Athersys, Inc.

OTCPK:ATHX.Q Voorraadrapport

Marktkapitalisatie: US$6.2k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Athersys Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijn2.1yrs
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Athersys: Is Big Pharma Sleeping At The Wheel?

Oct 06

Athersys extends exercise period of warrants in connection with recent offering

Sep 23

Athersys announces 1-for-25 reverse stock split

Aug 25

One Analyst's Revenue Estimates For Athersys, Inc. (NASDAQ:ATHX) Are Surging Higher

Aug 16
One Analyst's Revenue Estimates For Athersys, Inc. (NASDAQ:ATHX) Are Surging Higher

Athersys stock falls ~9% after reporting Q2 loss, fall in cash and cash equivalents

Aug 12

Kasey Rosado named interim CFO of Athersys

Aug 04

Athersys: Dead Man Walking

Jul 25

Athersys: Focus On Stroke

May 04

Athersys - Hero Or Zero Opportunity

Apr 18

Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022

Jan 20

Here's Why Athersys (NASDAQ:ATHX) Must Use Its Cash Wisely

Dec 30
Here's Why Athersys (NASDAQ:ATHX) Must Use Its Cash Wisely

Athersys: COVID-ARDS Is The Company's Most Important Target

Nov 25

Athersys Shares Are Ready To Rumble Following Period Of Turmoil

Aug 30

Athersys: Subgroup Analysis As A Masterstroke

Jul 29

Here's Why We're Watching Athersys' (NASDAQ:ATHX) Cash Burn Situation

May 28
Here's Why We're Watching Athersys' (NASDAQ:ATHX) Cash Burn Situation

Is Athersys (NASDAQ:ATHX) In A Good Position To Invest In Growth?

Feb 27
Is Athersys (NASDAQ:ATHX) In A Good Position To Invest In Growth?

Update On Athersys - Trying To Read Between The Lines

Feb 03

Athersys: Risky Financial Position, But Promising Upside By FYE 2023

Feb 01

Athersys: Stem Cell Opportunity For Risk Tolerant Investors

Nov 12

CEO

Athersys heeft geen CEO, of we hebben geen gegevens over hen.

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Z. Rosado
Interim CFO & Director2.1yrsUS$1.51mgeen gegevens
Senthil Ranganathan
Vice President of Technical Operations1.7yrsgeen gegevensgeen gegevens
David Russ
Vice President of Supply Chain1.7yrsgeen gegevensgeen gegevens
Manal Morsy
Executive VP & Head of Global Regulatory Affairs11.7yrsgeen gegevensgeen gegevens
Robert Mays
Executive VP8.2yrsgeen gegevensgeen gegevens
Rakesh Ramachandran
Head of Information Technology & Communications and VP7.7yrsgeen gegevensgeen gegevens
Sarah Busch
VP of Regenerative Medicine & Head of Business Development1.7yrsgeen gegevensgeen gegevens
Ellen Gurley
Manager of Corporate Communications and Investor Relationsno datageen gegevensgeen gegevens

2.1yrs

Gemiddelde duur

Ervaren management: Het managementteam van ATHX.Q wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.1 jaar).